Online citations, reference lists, and bibliographies.

Intrapleural Hypotonic Cisplatin Treatment For Malignant Pleural Mesothelioma: In Vitro Experiments And Clinical Application

T. Tagawa, I. Yoshino, M. Yamaguchi, A. Osoegawa, T. Kameyama, S. Fukuyama, T. Kometani, Y. Maehara
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PurposeWe studied the inhibitory effects of hypotonic cisplatin on the growth of malignant pleural mesothelioma (MPM) cell lines in vitro, and assessed the effectiveness of intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy for patients with this tumor.MethodsIn the in vitro experiments, mesothelioma cell lines were exposed to various concentrations of cisplatin in either saline solution or distilled water for up to 5 min. After 48 h incubation, we calculated the inhibition of cell growth. In the clinical study, five patients with MPM underwent intraoperative intrapleural hypotonic cisplatin treatment combined with extrapleural pneumonectomy.ResultsThe hypotonic cisplatin treatment inhibited cell growth at a significantly greater rate than the isotonic cisplatin treatment. Just 1–5 min exposure to 10 µg/ml of hypotonic cisplatin inhibited growth by more than 80%. Clinically, no recurrence was found in four of the five patients after a median follow-up period of 27 months (range: 16–36 months), although contralateral multiple pulmonary metastases were found in one patient 10 months after surgery.ConclusionHypotonic cisplatin treatment is effective against MPM, and should be investigated further.
This paper references
10.1200/JCO.1999.17.1.25
Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study.
M. Byrne (1999)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1067/MTC.2002.120712
A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention.
Y. Ichinose (2002)
10.1136/thx.39.4.255
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.
M. Law (1984)
10.1378/chest.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
10.1002/(SICI)1096-9098(199711)66:3<196::AID-JSO8>3.0.CO;2-7
Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis.
Y. Ichinose (1997)
Pharmacological basis for a novel therapeutic strategy based on the use of aquated cisplatin.
H. Zheng (1997)
10.1016/0169-5002(91)91773-5
Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. In vitro experiments and preliminary clinical results.
Y. Ichinose (1993)
10.1002/(SICI)1097-0142(19990415)85:8<1740::AID-CNCR14>3.0.CO;2-9
Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura
S. Kasseyet (1999)
10.1016/S0003-4975(96)01228-3
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
E. Baldini (1997)
10.1007/S002680020021
Treatment of Malignant Mesothelioma
M. Jaklitsch (2001)
Effect of osmotic pressure on uptake of chemotherapeutic agents by carcinoma cells.
R. Stephen (1990)
10.1378/chest.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
V. Rusch (1996)
10.1016/S0022-5223(96)70342-2
The importance of surgical staging in the treatment of malignant pleural mesothelioma.
V. Rusch (1996)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar